---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-114467"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2024-10-15T23:59:59+00:00"
generated_at: "2026-05-30T14:36:59.160728+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Iterum receives Nasdaq delisting notice, hearing set for Nov 21 on equity compliance

## Summary
- Nasdaq notified Iterum on Oct 1 of delisting for failing to meet $2.5M stockholders' equity requirement after Sep 30 extension deadline.
- Company requested hearing; Nasdaq Hearings Panel will consider appeal on November 21, 2024.
- Trading of ITRM ordinary shares continues on Nasdaq Capital Market pending hearing outcome.
- Panel may grant compliance extension up to March 31, 2025, but no assurance of success.

## SEC filing metadata
- accession: 0000950170-24-114467
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2024-10-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000095017024114467/0000950170-24-114467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000095017024114467/itrm-20241009.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-114467
- JSON: https://secwatch.observer/filing/0000950170-24-114467.json
- Plain text: https://secwatch.observer/filing/0000950170-24-114467.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.